1. David Moatazedi: President and CEO
David Moatazedi has over two decades of experience in the healthcare industry, specializing in pharmaceuticals and medical devices. Prior to joining Evolus, he served as Senior Vice President and General Manager of the US Dermatology business at Allergan.
2. Lauren Silvernail: Chief Financial Officer and Executive Vice President
Lauren Silvernail has over 20 years of experience in corporate finance, accounting, and operations. She has held senior finance roles at public and private companies in different sectors, including healthcare, technology, and retail.
3. Rui Avelar: Chief Medical Officer and Executive Vice President
Rui Avelar is a physician and anesthesiologist with extensive experience in the pharmaceutical and medical device industry. Prior to joining Evolus, he was the Vice President of Medical Affairs at Actavis, where he oversaw the clinical development and medical affairs activities of the US branded business.
4. Michael Jafar: Senior Vice President of Operations and Product Development
Michael Jafar has over 25 years of experience in operations, supply chain management, and product development. Before joining Evolus, he held executive positions at various medical device and pharmaceutical companies, including St. Jude Medical and Allergan.
5. Troy C. Thompson: Independent Director
Troy Thompson has over 25 years of experience in the pharmaceutical, medical device, and biotechnology industries. He has held executive positions at companies such as Amgen, Novartis, and Medtronic.
6. Kristine Ball: Independent Director
Kristine Ball has over 25 years of experience in the financial services industry, specializing in investment banking and private equity. She has held senior roles at firms such as JPMorgan Chase and Goldman Sachs.
Balbir Brar: Independent Director
Balbir Brar has over 30 years of experience in the healthcare industry, with expertise in pharmaceuticals, biotechnology, and medical devices. He has served as the Chief Medical Officer of several companies, including Ardea Biosciences and Somaxon Pharmaceuticals.
Evolus Inc currently has 334 employees.
News about Evolus Inc Key Personnel |
Introduction
Evolus Inc., a performance beauty company dedicated to developing a robust aesthetic portfolio of consumer brands, has recently announced the appointment of Nareg Sagherian as Vice President, Head of Global Investor Relations and Corporate Communications. With an immense expertise in the field, Sagherian s arrival heralds a new era for Evolus as it strives to engage with current and prospective investors and foster a strategic investor relations and corporate communications program. This strategic move comes at a crucial time for the company, as it looks to address its net loss and improve its return on investment (ROI) figures.
Enhancing Investor Relations
One of the primary re...
|
